Slitrk2 (extracellular) Blocking Peptide (#BLP-SR082) is the original antigen used for immunization during Anti-Slitrk2 (extracellular) Antibody (#ASR-082) generation. The blocking peptide binds and ‘blocks’ Anti-Slitrk2 (extracellular) primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
- Western blot analysis of mouse (lanes 1 and 3) and rat (lanes 2 and 4) brain lysates:
- Western blot analysis of human U-87 MG glioblastoma cell line lysate:
- Expression of Slitrk2 in rat striatumImmunohistochemical staining of perfusion-fixed frozen rat brain sections with Anti-Slitrk2 (extracellular) Antibody (#ASR-082), (1:200), followed by goat anti-rabbit-AlexaFluor-488. Slitrk2 immunoreactivity (green) appears in striosomal patches (S). Cell nuclei are stained with DAPI (blue).
- (C)KASRPPKMRNRPTPR, corresponding to amino acid residues 301-315 of mouse Slitrk2 (Accession Q810C0).